Astrana Health, Inc. provided earnings guidance for the year ending December 31, 2024. For the year, the company expects total revenue in the range of $1,650.0 million to $1,850.0 million, Net income attributable to Astrana Health, Inc. in the range of $61.0 million to $73.0 million and EPS ? diluted in the range of $1.28 to $1.52.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.89 USD | -0.41% | +3.82% | +1.54% |
08/05 | Stifel Cuts Price Target on Astrana Health to $45 From $50, Maintains Buy Rating | MT |
07/05 | Transcript : Astrana Health, Inc., Q1 2024 Earnings Call, May 07, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.54% | 1.85B | |
+20.68% | 85.55B | |
-29.31% | 70.07B | |
+9.65% | 29.06B | |
-8.63% | 17.51B | |
+2.14% | 17.39B | |
+0.39% | 15.38B | |
+6.47% | 13.4B | |
+68.09% | 12.87B | |
+6.43% | 12.77B |
- Stock Market
- Equities
- ASTH Stock
- News Astrana Health, Inc.
- Astrana Health, Inc. Provides Earnings Guidance for the Year Ending December 31, 2024